Cargando…

Updated Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol

Detalles Bibliográficos
Autores principales: Pawar, Ajinkya, Desai, Rishi J., Liu, Jun, Kim, Erin, Kim, Seoyoung C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174329/
https://www.ncbi.nlm.nih.gov/pubmed/33764153
http://dx.doi.org/10.1161/JAHA.120.020045
_version_ 1783702886270631936
author Pawar, Ajinkya
Desai, Rishi J.
Liu, Jun
Kim, Erin
Kim, Seoyoung C.
author_facet Pawar, Ajinkya
Desai, Rishi J.
Liu, Jun
Kim, Erin
Kim, Seoyoung C.
author_sort Pawar, Ajinkya
collection PubMed
description
format Online
Article
Text
id pubmed-8174329
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-81743292021-06-11 Updated Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol Pawar, Ajinkya Desai, Rishi J. Liu, Jun Kim, Erin Kim, Seoyoung C. J Am Heart Assoc Research Letter John Wiley and Sons Inc. 2021-03-25 /pmc/articles/PMC8174329/ /pubmed/33764153 http://dx.doi.org/10.1161/JAHA.120.020045 Text en © 2021 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Letter
Pawar, Ajinkya
Desai, Rishi J.
Liu, Jun
Kim, Erin
Kim, Seoyoung C.
Updated Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol
title Updated Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol
title_full Updated Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol
title_fullStr Updated Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol
title_full_unstemmed Updated Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol
title_short Updated Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol
title_sort updated assessment of cardiovascular risk in older patients with gout initiating febuxostat versus allopurinol
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174329/
https://www.ncbi.nlm.nih.gov/pubmed/33764153
http://dx.doi.org/10.1161/JAHA.120.020045
work_keys_str_mv AT pawarajinkya updatedassessmentofcardiovascularriskinolderpatientswithgoutinitiatingfebuxostatversusallopurinol
AT desairishij updatedassessmentofcardiovascularriskinolderpatientswithgoutinitiatingfebuxostatversusallopurinol
AT liujun updatedassessmentofcardiovascularriskinolderpatientswithgoutinitiatingfebuxostatversusallopurinol
AT kimerin updatedassessmentofcardiovascularriskinolderpatientswithgoutinitiatingfebuxostatversusallopurinol
AT kimseoyoungc updatedassessmentofcardiovascularriskinolderpatientswithgoutinitiatingfebuxostatversusallopurinol